Key Points . . . ➤ The number of studies focused on depression in men with prostate cancer is small in comparison to similar studies conducted with a focus on women with breast cancer.
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. Prostate cancer ranks second to lung cancer as the most common cause of cancer death among U.S. men across all racial and ethnic populations (American Cancer Society, 2005; Howe et al., 2001 ). Although incidence rates have been declining since 1993, the number of men and their signifi cant others affected by prostate cancer and its diagnosis and treatment is increasing. This trend is the result of the combined impact of widespread adoption of prostate-specifi c antigen screening, increased survival rates, and the overall growth and aging of the U.S. population (Edwards et al., 2002 ). An estimated 232,090 new prostate cancer cases and 30,350 deaths are expected in 2005 (American Cancer Society).
Prostate cancer symptoms and side effects of treatment may include pain, fatigue, and impairment in urinary and sexual functioning. As a result, in addition to mortality concerns, men with prostate cancer are at risk for psychological distress (Kunkel, Bakker, Myers, Oyesanmi, & Gomella, 2000) . The prevalence of psychological distress in this population has been reported as high as 31% (Zabora, Brintzenhofeszoc, Curbow, Hooker, & Piantadosi, 2001) . The clinical signifi cance of psychological distress, particularly depression, experienced by men with prostate cancer has yet to be addressed adequately in the research literature. Few studies have empirically examined the prevalence of depression in men with prostate cancer. Similarly, few experimental studies have tested the effectiveness of interventions targeting depression or mood as outcomes. Although the literature is sparse, a need exists to organize the available research to chart the direction for future investigations. The purpose of this article is to provide a comprehensive summary of the existing empirical knowledge base on depression in men with prostate cancer. Implications for future research will be presented based on an analysis of the strengths and weaknesses of the existing literature.
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